Quick Answer
Envoy Medical, Inc. reported Operating Income of -$22.27 million for fiscal year 2025.
Envoy Medical, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$22.27M | -15.7% |
| 2024 | -$19.26M | -4.9% |
| 2023 | -$18.36M | -110.9% |
| 2022 | -$8.71M | -67.3% |
| 2021 | -$5.20M | -742406.4% |
| 2020 | -$701.00 | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.71M | -14.8% | -12.6% |
| June 30, 2025 | -$5.07M | -4.5% | +0.7% |
| March 31, 2025 | -$5.11M | -4.6% | -2.7% |
| September 30, 2024 | -$4.97M | -46.9% | -2.5% |
| June 30, 2024 | -$4.85M | -8.3% | +0.7% |
| March 31, 2024 | -$4.88M | -29.5% | -44.3% |
| September 30, 2023 | -$3.38M | -88.5% | +24.4% |
| June 30, 2023 | -$4.48M | -397.0% | -18.8% |
- Envoy Medical, Inc. showed a decrease of -15.7% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Envoy Medical, Inc.’s operating income has declined by 3176790.2% (from -$701.00 to -$22.27 million).
- The most recent figure is from Envoy Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: